Liljeblad & Co Aktiebolag — CEO
Roles
15.09.2026 – 15.09.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 15.09.2026 | Prostatype Genomics AB Stockholm | Option exercise | 1,437,500 | SEK 0.10 | SEK 143,750.00 | ↗ |
| 15.09.2026 | Prostatype Genomics AB Stockholm | Option exercise | 1,437,500 | — | No cash value 1,437,500 units | ↗ |